Topics of current interest in the field, offered as lectures, conferences, or laboratory. Offered: AWSpS.
Cardiovascular disease (CVD) affects nearly 80 million adult Americans, costing an estimated $475 billion in 2009 alone. Experts claim that CVD is rapidly becoming a global epidemic, second only to HIV/AIDS. This seminar course will explore novel genetic, cellular, and tissue engineering approaches to treating CVD. Basic cardiac physiology will be taught to facilitate understanding of therapeutic approaches. Innovative treatments to be examined will include exon skipping, stem cell therapy, and development of biomaterials for tissue regeneration. Societal perceptions, ethical implications, and the impact of these approaches on policy will also be discussed.
Student learning goals
Understanding of basic cardiac function (assessed in quizzes)
Read and critique primary scientific literature (assessed by weekly written assignment)
Knowledge of potential new therapies for cardiac disease (assessed in quizzes)
Develop an ethical context for biomedical research (assessed by group participation)
Effectively communicate scientific concepts to peers and to the public (assessed by oral presentation)
General method of instruction
Students must have completed a 300-level course in Biology or Bioengineering.
Class assignments and grading